Mutations in EMP2 cause childhood-onset nephrotic syndrome

Mutations in EMP2 cause childhood-onset nephrotic syndrome.

Gee HY, Ashraf S, Wan X, Vega-Warner V, Esteve-Rudd J, Lovric S, Fang H, Hurd TW, Sadowski CE, Allen SJ, Otto EA, Korkmaz E, Washburn J, Levy S, Williams DS, Bakkaloglu SA, Zolotnitskaya A, Ozaltin F, Zhou W, Hildebrandt F.

Am J Hum Genet. 2014 Jun 5;94(6):884-90. doi: 10.1016/j.ajhg.2014.04.010. Epub 2014 May 8.

PMID: 24814193


Share this FacebooktwitterredditlinkedinmailFacebooktwitterredditlinkedinmail

AKESOgen, Inc. Announces the Appointment of Barbara Glazer to Director, Compliance & Clinical Trial Project Management.

AKESOgen, Inc. is pleased to announce the appointment of Barbara Glazer to the position of Director, Compliance & Clinical Trial Project Management. Ms. Glazer graduated from the University of Pittsburgh and has had a career as a laboratorian, building on experience in hospital and reference laboratories to move into clinical trials project management and operations management where she served for 17 years at Quintiles Laboratories. Ms. Glazer led one of the first biobanks to achieve College of American Pathologists (CAP) accreditation for biorepositories and is a member of the International Society for Biological and Environmental Repositories (ISBER) and the Biospecimen Science working group. Ms. Glazer’s presentations have included Quality Management Systems shipping and logistics of biological samples, among others. Additionally, she is Chair of the Advisory Board at Atlanta Technical College Bioscience Technology.

Share this FacebooktwitterredditlinkedinmailFacebooktwitterredditlinkedinmail